|Day Low/High||6.64 / 7.43|
|52 Wk Low/High||3.75 / 16.86|
A pair of earnings report this week will shed light on the future direction of two fast-growing companies in very different fields.
Five top marijuana stocks and four CBD plays in this speculative space.
A huge week is coming up for these well-known stocks.
This quarter is a heavy test for Tilray because of the stock's lofty valuation.
This $12 billion industry could rise to around $630 billion over time, according to Seaport analysts.
And the winners so far outnumber the losers among the six stocks that include a cannabis company, a couple financial giants and two oil plays.
Right now they are speculative growth stocks through and through.
Without Apple doing so well Monday the indices would look much different.
Stick to your methodology and don't let worry of underperformance push you to shift your approach.
I think it's a good thing that CEO Vic Neufeld and co-founder Cole Cacciavillani are leaving the company.
This is the kind of reversal that happens in a bull market.
After a difficult quarter for the marijuana sector, two of the most successful cannabis ETFs have added to their basket of stocks.
The start to 2019 looks to be much more promising for the cannabis industry than last year.
Both Aphria and Green Growth's stock prices have sold off since the announcement.
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
During a time when the broader market is facing uncertainty, I'm willing to start hunting.
The tobacco giant is being threatened on two fronts: e-cigarettes in the form of Juul and cannabis.
Consumer Discretionary stocks were the hottest on Wednesday, though all eleven sectors easily finished in the green.